0001140361-23-029899.txt : 20230614
0001140361-23-029899.hdr.sgml : 20230614
20230614182754
ACCESSION NUMBER: 0001140361-23-029899
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230613
FILED AS OF DATE: 20230614
DATE AS OF CHANGE: 20230614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Maples Sharon J.
CENTRAL INDEX KEY: 0001524612
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22427
FILM NUMBER: 231015471
MAIL ADDRESS:
STREET 1: 3760 ROCKY MOUNTAIN AVENUE
CITY: LOVELAND
STATE: CO
ZIP: 80538
FORMER NAME:
FORMER CONFORMED NAME: Larson Sharon J.
DATE OF NAME CHANGE: 20170223
FORMER NAME:
FORMER CONFORMED NAME: Riley Sharon L.
DATE OF NAME CHANGE: 20110629
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HESKA CORP
CENTRAL INDEX KEY: 0001038133
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 770192527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3760 ROCKY MOUNTAIN AVENUE
CITY: LOVELAND
STATE: CO
ZIP: 80538
BUSINESS PHONE: 9704937272
MAIL ADDRESS:
STREET 1: 3760 ROCKY MOUNTAIN AVENUE
CITY: LOVELAND
STATE: CO
ZIP: 80538
4
1
form4.xml
X0407
4
2023-06-13
true
0001038133
HESKA CORP
HSKA
0001524612
Maples Sharon J.
3760 ROCKY MOUNTAIN AVENUE
LOVELAND
CO
80538
true
false
Common Stock
2023-06-13
4
D
0
8608
120
D
0
D
Non-Qualified Stock Option (right to buy)
39.56
2023-06-13
4
D
0
3571
D
2016-05-13
2026-05-12
Common Stock
3571
0
D
Disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 31, 2023, by and among the Issuer, Antech Diagnostics, Inc., a California corporation ("Acquiror"), Helsinki Merger Sub LLC, a Delaware limited liability company and a wholly-owned subsidiary of Acquiror, and, solely for purposes of Section 9.15 of the Merger Agreement, Mars, Incorporated, a Delaware corporation, in exchange for cash consideration of $120.00 per share of common stock of the Issuer (the "Merger Consideration") on the effective date of the merger.
Stock options of the Issuer were canceled in the merger in exchange for an amount in cash equal to the difference, if any, between the Merger Consideration and the exercise price of such stock options.
/s/ By: Catherine Grassman For: Sharon J. Maples
2023-06-13